Antiapoptotic role of the p38 mitogen-activated protein kinase–myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation

  • Shu-ichi Okamoto
    Center for Neuroscience and Aging, The Burnham Institute, La Jolla, CA 92037; and Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital, Division of Neuroscience, Children's Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA 02115
  • Dimitri Krainc
    Center for Neuroscience and Aging, The Burnham Institute, La Jolla, CA 92037; and Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital, Division of Neuroscience, Children's Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA 02115
  • Katerina Sherman
    Center for Neuroscience and Aging, The Burnham Institute, La Jolla, CA 92037; and Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital, Division of Neuroscience, Children's Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA 02115
  • Stuart A. Lipton
    Center for Neuroscience and Aging, The Burnham Institute, La Jolla, CA 92037; and Cerebrovascular and NeuroScience Research Institute, Brigham and Women's Hospital, Division of Neuroscience, Children's Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA 02115

書誌事項

公開日
2000-06-13
DOI
  • 10.1073/pnas.130502697
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Myocyte enhancer factor 2 (MEF2) is in the MADS (MCM1agamous-deficiens-serum response factor) family of transcription factors. Although MEF2 is known as a myogenic factor, the expression pattern of the MEF2 family of genes (MEF2A-D) in developing brain also suggests a role in neurogenesis. Here we show that transfection with MEF2C, the predominant form in mammalian cerebral cortex, induces a mixed neuronal/myogenic phenotype in undifferentiated P19 precursor cells. During retinoic acid-induced neurogenesis of these cells, a dominant negative form of MEF2 enhances apoptosis but does not affect cell division. The mitogen-activated protein kinase p38α activates MEF2C. Dominant negative p38α also enhances apoptotic death of differentiating neurons, but these cells can be rescued from apoptosis by coexpression of constitutively active MEF2C. These findings suggest that the p38α/MEF2 pathway prevents cell death during neuronal differentiation.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ